• About us
• Contact

Advertisement

Organisation › Details

Albireo Pharma Inc. (Nasdaq: ALBO)

Albireo Pharma, Inc. (NASDAQ:ALBO), is a clinical-stage company focused on the development of therapies for orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo’s lead product candidate, A4250, is an ileal bile acid transporter (IBAT) inhibitor in phase 2 of development for pediatric cholestatic liver diseases, initially progressive familial intrahepatic cholestasis (PFIC). Albireo's pipeline includes assets in phase 3 for chronic constipation, phase 2 for bile acid malabsorption and pre-clinical development for NASH. Albireo Pharma is headquartered in Boston, Massachusetts and its operating subsidiary is located in Gothenburg, Sweden. *

 

	Start	2020-07-11 existent
	Industry	DRUGS, ORPHAN
	Industry 2	Bylvay®
	City	n. a. Boston, MA
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-01-21

Advertisement

More documents for Ipsen (Group)

• [1] Ipsen S.A.. (1/9/23). "Press Release: Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases". Paris & Boston, MA....
• [2] Genmab A/S. (3/11/19). "Press Release: Genmab Announces Appointment of Marisol Peron as Head of Communications and Investor Relations". Copenhagen....
• [3] Uniqure N.V.. (6/13/18). "Press Release: Uniqure Announces New Appointments to its Board of Directors". Lexington, MA & Amsterdam....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.